Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2017 at "Hepatology"
DOI: 10.1002/hep.29005
Abstract: Eight weeks duration of ledipasvir/sofosbuvir (LDV/SOF) can be considered in genotype 1 hepatitis C virus–infected patients who are treatment‐naive, do not have cirrhosis, and have a pretreatment viral load
read more here.
Keywords:
ldv sof;
eight weeks;
treatment;
relapse ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2018 at "Hepatology"
DOI: 10.1002/hep.30123
Abstract: Currently, there are no interferon‐free treatments available for hepatitis C virus (HCV)–infected patients younger than 12 years. We evaluated the safety and effectiveness of the all‐oral regimen ledipasvir–sofosbuvir ± ribavirin in HCV‐infected children aged 6…
read more here.
Keywords:
hepatitis;
hcv;
safety;
sofosbuvir ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Medical Virology"
DOI: 10.1002/jmv.24767
Abstract: There is little information on retreatment efficacy and predictors of the combination of ledipasvir and sofosbuvir (ledipasvir/sofosbuvir) for patients who fail to respond to NS5A inhibitors. NS5A resistance variants are known to persist for long…
read more here.
Keywords:
response;
prior ns5a;
treatment;
hcv genotype ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Drugs"
DOI: 10.1007/s40265-018-0864-z
Abstract: Oral once-daily, fixed-dose, ledipasvir/sofosbuvir (Harvoni®) [± ribavirin] is approved in several countries for the treatment of chronic hepatitis C (CHC) in adults and adolescents aged 12 to
read more here.
Keywords:
ribavirin;
infection;
sofosbuvir;
ledipasvir sofosbuvir ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Advances in medical sciences"
DOI: 10.1016/j.advms.2017.04.004
Abstract: BACKGROUND To evaluate the effectiveness and safety of ledipasvir/sofosbuvir (LDV/SOF)±ribavirin (RBV) regimen in a real-world setting. METHODS Patients received a fixed-dose combination tablet containing LDV and SOF with or without RBV, for 8, 12 or…
read more here.
Keywords:
real world;
effectiveness safety;
treatment;
ledipasvir sofosbuvir ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2017.01.016
Abstract: The effectiveness of ledipasvir/sofosbuvir (LDV/SOF) in routine use in clinical practice for the management of chronic hepatitis C virus (HCV) has not been well described. Data with prior agents suggest that management of HCV using…
read more here.
Keywords:
chronic hepatitis;
ldv sof;
treatment;
effectiveness ledipasvir ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Pediatric Gastroenterology and Nutrition"
DOI: 10.1097/mpg.0000000000003406
Abstract: ABSTRACT Objectives: In children with hematological malignancies, chronic hepatitis C virus (HCV) infection has been associated with more rapid liver disease progression and higher risk of malignancy relapse due to chemotherapy interruption. We evaluated the…
read more here.
Keywords:
ledipasvir sofosbuvir;
adolescents chronic;
chronic hepatitis;
hcv ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of clinical pharmacy and therapeutics"
DOI: 10.1111/jcpt.13624
Abstract: WHAT IS KNOWN AND OBJECTIVE In Japan, ledipasvir/sofosbuvir, elbasvir/grazoprevir and glecaprevir/pibrentasvir are recommended as first-line treatments for patients with untreated hepatitis C virus genotype 1. Although they have demonstrated a high efficacy in clinical trials,…
read more here.
Keywords:
response;
glecaprevir pibrentasvir;
ledipasvir sofosbuvir;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02491-18
Abstract: Doravirine is a non-nucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Due to the high prevalence of HIV-1 and hepatitis C virus (HCV) coinfection and coadministration of HIV-1…
read more here.
Keywords:
ledipasvir sofosbuvir;
doravirine;
elbasvir grazoprevir;
grazoprevir ledipasvir ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Pharmacy Practice"
DOI: 10.1177/0897190017744421
Abstract: Sexual dysfunction is a bothersome side effect of several medications, though it has not yet been reported with the use of ledipasvir/sofosbuvir for the treatment of hepatitis C. However, sexual dysfunction is a potentially unrecognized…
read more here.
Keywords:
sexual dysfunction;
hepatitis;
treatment;
dysfunction ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Internal Medicine"
DOI: 10.2169/internalmedicine.9744-17
Abstract: Combination therapy with ledipasvir and sofosbuvir (LDV/SOF), direct-acting antiviral agents, is highly effective against hepatitis C virus genotype 1 infection. Although LDV/SOF is safer than conventional treatment, reports have indicated that LDV/SOF was discontinued in…
read more here.
Keywords:
skin disorders;
ldv sof;
treatment;
sof ... See more keywords